This inventor holds 2 USPTO granted patents. Top assignee: Ciba-Geigy Corporation. Active years: 1977-1978.
Company Filing History:
Years Active: 1977-1978
Title: Charles Meystre: Innovator in Steroid Chemistry
Introduction
Charles Meystre is a notable inventor based in Reinach, Switzerland. He has made significant contributions to the field of steroid chemistry, holding a total of 2 patents. His work focuses on the development of novel compounds with potential therapeutic applications.
Latest Patents
Meystre's latest patents include innovative formulations that demonstrate anti-inflammatory and thymolytic actions. One patent details the synthesis of aldehydes of the pregnane series and their derivatives, specifically highlighting the derivatives of 1-dehydro-6.alpha.,9.alpha.-difluoro-16.alpha.-methyl-corticosterone. These compounds feature an aldehyde group in the 21-position, replacing the hydroxyl group, and include derivatives with a 2-chlorine atom, as well as their functional aldehyde derivatives such as acetals. The preparation of these compounds is achieved through conventional methods.
Another significant patent involves a process for manufacturing spiro compounds of the steroid series. This process utilizes a 17-oxosteroid and an organometallic compound to create compounds with specific structural characteristics, including double bonds and methyl groups in designated positions.
Career Highlights
Charles Meystre has been associated with Ciba-Geigy Corporation, a prominent player in the pharmaceutical and chemical industries. His work has contributed to advancements in steroid chemistry, enhancing the understanding and application of these compounds in medical science.
Collaborations
Throughout his career, Meystre has collaborated with esteemed colleagues such as Georg Anner and Adrian Marxer. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Charles Meystre's contributions to steroid chemistry through his patents reflect his dedication to innovation in the field. His work continues to influence the development of therapeutic compounds, showcasing the importance of research and collaboration in scientific advancement.